Literature DB >> 20148634

Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields.

Mark Pickard1, Divya Chari.   

Abstract

AIMS: To assess the feasibility of using magnetic nanoparticles (MNPs) to transfect astrocytes derived for transplantation and determine if transfection efficacy can be enhanced by static and oscillating magnetic fields.
METHODS: Astrocytes were transfected using MNPs functionalized with a plasmid encoding a reporter protein. Transfection efficacies were compared following application of static fields and a novel, oscillating array system at a range of frequencies. The transplantation potential of transfected cells was tested in organotypic cerebellar slice cultures.
RESULTS: Rat astrocytes can be efficiently transfected using MNPs with applied static/oscillating fields; the latter effect is frequency dependent. Transfected astrocytes could survive and differentiate following introduction into 3D neural tissue arrays.
CONCLUSION: MNP vectors can safely and effectively transfect rodent astrocytes and could form the basis of a 'multifunctional nanoplatform' for neural cell transplantation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20148634     DOI: 10.2217/nnm.09.109

Source DB:  PubMed          Journal:  Nanomedicine (Lond)        ISSN: 1743-5889            Impact factor:   5.307


  21 in total

1.  Endocytotic potential governs magnetic particle loading in dividing neural cells: studying modes of particle inheritance.

Authors:  Jacqueline A Tickle; Stuart I Jenkins; Boris Polyak; Mark R Pickard; Divya M Chari
Journal:  Nanomedicine (Lond)       Date:  2016-01-20       Impact factor: 5.307

2.  Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents.

Authors:  Fatema Tuj Zohra; Mikhail Medved; Nina Lazareva; Boris Polyak
Journal:  Nanomedicine (Lond)       Date:  2015-05       Impact factor: 5.307

3.  Improved transfection of HUVEC and MEF cells using DNA complexes with magnetic nanoparticles in an oscillating field.

Authors:  Jenson Lim; Jon Dobson
Journal:  J Genet       Date:  2012-08       Impact factor: 1.166

4.  Fe3O4-PEI-RITC magnetic nanoparticles with imaging and gene transfer capability: development of a tool for neural cell transplantation therapies.

Authors:  Humphrey H P Yiu; Mark R Pickard; Cristina I Olariu; Stephen R Williams; Divya M Chari; Matthew J Rosseinsky
Journal:  Pharm Res       Date:  2011-12-02       Impact factor: 4.200

Review 5.  Magnetic nanoparticle-based approaches to locally target therapy and enhance tissue regeneration in vivo.

Authors:  Richard Sensenig; Yulia Sapir; Cristin MacDonald; Smadar Cohen; Boris Polyak
Journal:  Nanomedicine (Lond)       Date:  2012-09       Impact factor: 5.307

6.  Force dependent internalization of magnetic nanoparticles results in highly loaded endothelial cells for use as potential therapy delivery vectors.

Authors:  Cristin MacDonald; Kenneth Barbee; Boris Polyak
Journal:  Pharm Res       Date:  2012-01-11       Impact factor: 4.200

Review 7.  Magnetically enhanced nucleic acid delivery. Ten years of magnetofection-progress and prospects.

Authors:  Christian Plank; Olivier Zelphati; Olga Mykhaylyk
Journal:  Adv Drug Deliv Rev       Date:  2011-08-26       Impact factor: 15.470

Review 8.  Handling of iron oxide and silver nanoparticles by astrocytes.

Authors:  Michaela C Hohnholt; Mark Geppert; Eva M Luther; Charlotte Petters; Felix Bulcke; Ralf Dringen
Journal:  Neurochem Res       Date:  2012-12-06       Impact factor: 3.996

9.  Robust uptake of magnetic nanoparticles (MNPs) by central nervous system (CNS) microglia: implications for particle uptake in mixed neural cell populations.

Authors:  Mark R Pickard; Divya M Chari
Journal:  Int J Mol Sci       Date:  2010-03-08       Impact factor: 6.208

10.  Delivery of short interfering ribonucleic acid-complexed magnetic nanoparticles in an oscillating field occurs via caveolae-mediated endocytosis.

Authors:  Jenson Lim; Michael A Clements; Jon Dobson
Journal:  PLoS One       Date:  2012-12-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.